4.1 Article

Activated clotting time test alone is inadequate to optimize therapeutic heparin dosage adjustment during post-cardiopulmonary resuscitational extracorporeal membrane oxygenation (e-CPR)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Engineering, Biomedical

Extracorporeal Life Support Organization Registry Report 2012

Matthew L. Paden et al.

ASAIO JOURNAL (2013)

Article Cardiac & Cardiovascular Systems

Unfractionated heparin dosing and risk of major bleeding in non-ST-segment elevation acute coronary syndromes

Chiara Melloni et al.

AMERICAN HEART JOURNAL (2008)

Review Hematology

The story of the discovery of heparin and warfarin

Douglas Wardrop et al.

BRITISH JOURNAL OF HAEMATOLOGY (2008)

Review Critical Care Medicine

Pharmacology and management of the vitamin K antagonists

Jack Ansell et al.

Article Cardiac & Cardiovascular Systems

Anticoagulation and pediatric extracorporeal membrane oxygenation: Impact of activated clotting time and heparin dose on survival

Christopher W. Baird et al.

ANNALS OF THORACIC SURGERY (2007)

Article Cardiac & Cardiovascular Systems

Coagulopathy after successful cardiopulmonary resuscitation following cardiac arrest - Implication of the protein C anticoagulant pathway

C Adrie et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)

Article Hematology

Methods for the monitoring of direct thrombin inhibitors

G Hafner et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2002)

Article Pharmacology & Pharmacy

Correlation between activated clotting time and activated partial thromboplastin times

MA Smythe et al.

ANNALS OF PHARMACOTHERAPY (2002)